"Peering into the pharmaceutical "pipeline
Investigational drugs, clinical trials, and industry priorities
Bibliographic Data
| ID | 4596841 |
|---|---|
| Authors | Jill A Fisher (0000-0002-9487-1493, University of North Carolina at Chapel Hill), Marci D Cottingham (0000-0003-3519-4100, University of North Carolina at Chapel Hill), Corey A Kalbaugh (0000-0002-7455-0369, University of North Carolina at Chapel Hill) |
| Year | 2015 |
| Volume | 131 |
| Pages | 322-330 |
| Publication date | 2015-04-01 |
| Peer Reviewed | Yes |
| Open Access | Yes |
| Type | ARTICLE |
| Venue | Social Science & Medicine (JOURNAL) |
| Journal identifiers | ISSN: 0277-9536 • E-ISSN: 1873-5347 |
| Publisher | Elsevier BV (PUBLISHER) |
| DOI | 10.1016/j.socscimed.2014.08.023 |
| PMID | 25159693 |
| PMCID | PMC4334744 |
| OpenAlex | W1975664878 |
| Language | EN |
| Citations received | 17 |
| References cited | 55 |
Business · Clinical trial · Context (archaeology · Drug · Drug development · Drug industry · Family medicine · Pathology · Pharmaceutical industry · Pipeline (software · Biotechnology and Related Fields · Computer Science · Engineering · Medicine · Pharmaceutical Economics and Policy · Pharmaceutical industry and healthcare · Pharmacology
Five insights from the Global Burden of Disease Study 2019
Global burden of 369 diseases and injuries in 204 countries and territories, 1990–2019
The demise of the antibiotic pipeline
This isn’t going to end well
The rise and fall of global health issues
Beyond unequal access
Shifting patterns and competing explanations for infectious disease priority in global health agenda setting arenas
Regulating Pharmaceutical Industry Marketing
Uso racional de medicamentos, farmaceuticalização e usos do metilfenidato
Trying to get down here when the dealer's closer
Just Advil
Is there evidence for the racialization of pharmaceutical regulation? Systematic comparison of new drugs approved over five years in the USA and the EU
Access to critical medicines
Pharmaceuticals and society
Beyond biomedical institutions
Bringing the Global into Medical Sociology
Treatment 'cultures', sexually transmitted infections and the rise of antimicrobial resistance
Prescribing by Numbers
Pharmaceutical industry sponsorship and research outcome and quality
The price of innovation
Research electronic data capture (Redcap)—A metadata-driven methodology and workflow process for providing translational research informatics support
Pleasure consuming medicine
Pharma in the bedroom . . . and the kitchen. . . . The pharmaceuticalisation of daily life
Marvelous medicines and dangerous drugs
When Experiments Travel
Getting to Yes
Dep®ession and Consum♀tion
Global Pharmaceutical Markets and Corporate Citizenship
Manufacturing Desire
Labor Pains
The Social Transformation of American Medicine
Biomedicalization
Clinical trials as treatment option
Listening to Lyrica
Gendering the migraine market
Medicalization and pharmaceuticalization at the intersections
A pill for every ill
Volunteer human subjects' understandings of their participation in a biomedical research experiment
Trials and tribulations
Scientific tools, fake treatments, or triggers for psychological healing
Demanding patient or demanding encounter
A comparative analysis of drug safety withdrawals in the UK and the US (1971-1992)
PharmAD-ventures
Labor Pains
Do People Fail Drugs, or Do Drugs Fail People
Side Effects
Hard Science
Pharmaceuticalization of Society in Context
The pharmaceuticalisation of society? A framework for analysis
Desperately seeking cancer drugs
In the vanguard of biomedicine? The curious and contradictory case of anti-ageing medicine
The sociology of pharmaceuticals
Sex, drugs, and politics
From Lydia Pinkham to Queen Levitra
Waking up to sleepiness
| Unique citing works | 17 |
|---|---|
| Citations per year | 1,55 |
| Citation span | 2015 - 2025 (11) |
| Citation velocity | recent |
| Highly cited | No |
| Citation types | Neutral: 17 |